Spotlight on clinical trials: Lord O’Shaughnessy visits Birmingham
This week we welcomed Lord James O’Shaughnessy to the University of Birmingham to showcase Birmingham’s transformational research and leadership in clinical trials, diagnostics and health data – underpinned by the Birmingham Health Partners ecosystem of which PHTA and BHIC are proudly part. A Member of the House of Lords since 2015, James served as Parliamentary […]
Double recognition for PHTA at Innovation Awards
Last week we were thrilled to be recognised as Highly Commended in two categories at the Innovation Awards 2023 which recognise, celebrate and reward the businesses, organisations and individuals who are dedicated to innovation. Our CEO, Gino Martini, was named runner-up in the Male Innovator of the Year category for his contribution to stimulating innovation and […]
PHTA in Parliament
Last week, members of our team were in the UK Houses of Parliament to showcase PHTA and emphasise its potential to bring high-skilled, well-paid jobs and economic growth to the region. Steve McCabe MP opened by introducing Birmingham’s heritage as the ‘City of 1,000 Trades’ and highlighting the life sciences sector as key to its […]
PHTA joins West Midlands Innovation Accelerator for new healthcare technologies
PHTA has today been announced as a partner in a major project to drive new healthcare technologies towards commercialisation, led by the University of Birmingham. Called the West Midlands Health Tech Innovation Accelerator, the project has received £14m in funding from the West Midlands Combined Authorities’ Innovation Accelerator which is part of an Innovate UK […]
$50m strategic investment for PHTA’s first resident
KIFFIK Biomedical, Inc., a biotechnology company supported by PHTA since 2022, has announced a major investment commitment from private alternative investment group GEM Global Yield – totalling up to $50m over the course of the next three years. Harnessing the power of interstitial fluid (IF)*, KIFFIK’s wearable, non-invasive technology creates micro-openings in the epidermis to […]
PHTA kicks off Birmingham Youth Sports Academy sponsorship
A youth charity dedicated to improving lives through sport has today received a £4,000 shirt sponsorship donation from PHTA Ltd as part of its commitment to reducing health inequality in the UK’s second city. Birmingham Youth Sport Academy (BYSA) offers professional football coaching to girls and boys aged 6-18, as well as mentoring, tutoring and […]
PHTA and Oxford Science Enterprises join forces to accelerate innovation
Early-stage life sciences enterprises are set to benefit from a unique new collaboration between Birmingham’s Precision Health Technologies Accelerator (PHTA) and Oxford Science Enterprises (OSE). The partnership will focus on helping high-growth health technology and life sciences companies to scale, primarily through access to high-quality lab and innovation space, while also catalysing cross-regional collaboration between […]
Watch: Life Science Success podcast
Life Science Success is a podcast interviewing high-performing, individuals in life sciences, covering their proven methods, principles, strategies, and mindsets to implement new technologies. Our CEO Gino Martini was invited to join host Don Davis PhD to discuss connecting clinicians and industry and creating an ecosystem for collaboration. Missed the live broadcast? Catch up below!
Intellectual property: the lifeblood of life sciences SMEs
Much has been written about the importance of intellectual property (IP) to global organisations, with several well-publicised copyright disputes among consumer brands in recent years. But what about SMEs – there are 5.9m in the UK alone – and specifically, what about life sciences businesses? What can IP do for them? To mark World IP […]
How can we increase the opportunities for women in science? With Kath Mackay
UK science continues to face a myriad of transformational challenges, including the ongoing impact of Britain’s exit from the European Union as one of the biggest, resulting in a potentially smaller pool of talent available for UK firms to choose from, a likely decline in foreign direct investment and a deviation away from regulatory norms. […]